期刊
BIOMEDICINES
卷 9, 期 3, 页码 -出版社
MDPI
DOI: 10.3390/biomedicines9030319
关键词
meningioma; central nervous system; tumor; benign; malignant
Meningiomas are the most common intracranial tumor, usually benign; treating meningiomas with complicated histology or in compromising locations is challenging; advances in genomics and molecular characteristics provide potential for more accurate grading and prognosis prediction.
Meningiomas are the most common intracranial tumor, making up more than a third of all primary central nervous system (CNS) tumors. They are mostly benign tumors that can be observed or preferentially treated with gross total resection that provides good outcomes. Meningiomas with complicated histology or in compromising locations has proved to be a challenge in treating and predicting prognostic outcomes. Advances in genomics and molecular characteristics of meningiomas have uncovered potential use for more accurate grading and prediction of prognosis and recurrence. With the study and detection of genomic aberrancies, specific biologic targets are now being trialed for possible management of meningiomas that are not responsive to standard surgery and radiotherapy treatment. This review summarizes current epidemiology, etiology, molecular characteristics, diagnosis, treatments, and current treatment trials.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据